Literature DB >> 20629138

Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS).

Christopher G Goetz1, Glenn T Stebbins, Teresa A Chmura, Stanley Fahn, Werner Poewe, Caroline M Tanner.   

Abstract

To accompany the newly developed Movement Disorder Society revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS), we developed a teaching program. The DVD-based program covers the four parts of the scale with visual and verbal instructions for uniform application. For the motor section (Part III), all items except rigidity are shown with an example of each rating option (0-4) as agreed upon by a panel of experts. The rate of agreement for the selected samples was always significant, with Kendall's coefficient of concordance W ranging between 0.99 and 0.72. The teaching program also provides a full patient examination with rating answers provided and four full MDS-UPDRS cases for a Certificate Program exercise of Part III. This training program is in English, but as non-English official translations of the MDS-UPDRS are developed, the program can be potentially modified into different languages.

Entities:  

Mesh:

Year:  2010        PMID: 20629138     DOI: 10.1002/mds.23096

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

1.  Case-control study of blink rate in Parkinson's disease under different conditions.

Authors:  Emily Fitzpatrick; Norman Hohl; Peter Silburn; Cullen O'Gorman; Simon A Broadley
Journal:  J Neurol       Date:  2011-10-08       Impact factor: 4.849

2.  Cross-Cultural Differences of the Non-Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society- Unified Parkinson's Disease Rating Scale.

Authors:  Rwei-Ling Yu; Ruey-Meei Wu; Anne Y Y Chan; Vincent Mok; Yih-Ru Wu; Barbara C Tilley; Sheng Luo; Lu Wang; Nancy R LaPelle; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord Clin Pract       Date:  2016-04-08

3.  Commonalities and challenges in the development of clinical trial measures in neurology.

Authors:  Jesse M Cedarbaum; Diane Stephenson; Richard Rudick; Maria C Carrillo; Glenn Stebbins; Douglas Kerr; Jill Heemskerk; Wendy R Galpern; Petra Kaufmann; David Cella; Maria Isaac; Marc K Walton
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

4.  Brain Connectivity Changes in Autosomal Recessive Parkinson Disease: A Model for the Sporadic Form.

Authors:  Elena Makovac; Mara Cercignani; Laura Serra; Mario Torso; Barbara Spanò; Simona Petrucci; Lucia Ricciardi; Monia Ginevrino; Carlo Caltagirone; Anna Rita Bentivoglio; Enza Maria Valente; Marco Bozzali
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

5.  Validation of the Italian version of the Movement Disorder Society--Unified Parkinson's Disease Rating Scale.

Authors:  Angelo Antonini; Giovanni Abbruzzese; Luigi Ferini-Strambi; Barbara Tilley; Jing Huang; Glenn T Stebbins; Christopher G Goetz; Paolo Barone; Monica Bandettini di Poggio; Giovanni Fabbrini; Flavio Di Stasio; Michele Tinazzi; Tommaso Bovi; Silvia Ramat; Sara Meoni; Gianni Pezzoli; Margherita Canesi; Paolo Martinelli; Cesa Lorella Maria Scaglione; Aroldo Rossi; Nicola Tambasco; Gabriella Santangelo; Marina Picillo; Letterio Morgante; Francesca Morgante; Rocco Quatrale; MariaChiara Sensi; Manuela Pilleri; Roberta Biundo; Giampietro Nordera; Antonella Caria; Claudio Pacchetti; Roberta Zangaglia; Leonardo Lopiano; Maurizio Zibetti; Mario Zappia; Alessandra Nicoletti; Aldo Quattrone; Maria Salsone; Gianni Cossu; Daniela Murgia; Alberto Albanese; Francesca Del Sorbo
Journal:  Neurol Sci       Date:  2012-06-08       Impact factor: 3.307

6.  A retrospective study of the clinical and electrophysiological characteristics of 32 patients with orthostatic myoclonus.

Authors:  J A van Gerpen
Journal:  Parkinsonism Relat Disord       Date:  2014-05-22       Impact factor: 4.891

7.  Unbiased and mobile gait analysis detects motor impairment in Parkinson's disease.

Authors:  Jochen Klucken; Jens Barth; Patrick Kugler; Johannes Schlachetzki; Thore Henze; Franz Marxreiter; Zacharias Kohl; Ralph Steidl; Joachim Hornegger; Bjoern Eskofier; Juergen Winkler
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

8.  Improvement of Advanced Parkinson's Disease Manifestations with Deep Brain Stimulation of the Subthalamic Nucleus: A Single Institution Experience.

Authors:  Ahmed Rabie; Leo Verhagen Metman; Mazen Fakhry; Ayman Youssef Ezeldin Eassa; Wael Fouad; Ahmed Shakal; Konstantin V Slavin
Journal:  Brain Sci       Date:  2016-12-13

9.  The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.

Authors:  Kenneth Marek; Sohini Chowdhury; Andrew Siderowf; Shirley Lasch; Christopher S Coffey; Chelsea Caspell-Garcia; Tanya Simuni; Danna Jennings; Caroline M Tanner; John Q Trojanowski; Leslie M Shaw; John Seibyl; Norbert Schuff; Andrew Singleton; Karl Kieburtz; Arthur W Toga; Brit Mollenhauer; Doug Galasko; Lana M Chahine; Daniel Weintraub; Tatiana Foroud; Duygu Tosun-Turgut; Kathleen Poston; Vanessa Arnedo; Mark Frasier; Todd Sherer
Journal:  Ann Clin Transl Neurol       Date:  2018-10-31       Impact factor: 4.511

10.  Large-Scale Wearable Sensor Deployment in Parkinson's Patients: The Parkinson@Home Study Protocol.

Authors:  Ana Lígia Silva de Lima; Tim Hahn; Nienke M de Vries; Eli Cohen; Lauren Bataille; Max A Little; Heribert Baldus; Bastiaan R Bloem; Marjan J Faber
Journal:  JMIR Res Protoc       Date:  2016-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.